Home Cart Sign in  
Chemical Structure| 1445251-22-8 Chemical Structure| 1445251-22-8

Structure of ME0328
CAS No.: 1445251-22-8

Chemical Structure| 1445251-22-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ME0328 is a potent and selective PARP inhibitor with IC50 of 0.89 μM for PARP3, about 7-fold selectivity over PARP1.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ME0328

CAS No. :1445251-22-8
Formula : C19H19N3O2
M.W : 321.37
SMILES Code : O=C(N[C@H](C1=CC=CC=C1)C)CCC(N2)=NC3=C(C=CC=C3)C2=O
MDL No. :MFCD27991291
InChI Key :QIHBWVVVRYYYRO-ZDUSSCGKSA-N
Pubchem ID :135566764

Safety of ME0328

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of ME0328

epigenetics
DNA

Isoform Comparison

Biological Activity

Target
  • PARP1

    PARP1, IC50:6.3 μM

  • PARP3

    PARP3, IC50:0.89 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
CHO cells 3 μmol/L 1 hour Evaluation of GW627368X antagonism at human prostanoid CRTH2, EP1, EP2, EP3, FP, and IP receptors, showing no significant antagonism at CRTH2, EP2, EP3, IP, and FP receptors. PMC8195440
A549 cells 3 μM Inhibited RSK4 activation, resulting in decreased cellular cIAP1 and cIAP2 expression PMC5414184

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.11mL

0.62mL

0.31mL

15.56mL

3.11mL

1.56mL

31.12mL

6.22mL

3.11mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories